Humacyte, Inc.
HUMA · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 14, 2026 | — | 1.12M | — | -0.10 | — |
| 2026 Q1 | May 13, 2026 | 495.00K | 1.46M | -0.09 | -0.10 | +24.18% |
| 2025 Q4 | March 27, 2026 | 467.00K | 1.35M | -0.13 | -0.13 | -13.21% |
| 2025 Q3 | November 12, 2025 | 753.00K | 1.35M | -0.14 | -0.17 | -2.34% |
| 2025 Q2 | August 11, 2025 | 301.00K | 917.83K | -0.24 | -0.15 | -29.64% |
| 2025 Q1 | May 13, 2025 | 517.00K | 764.83K | -0.10 | -0.19 | +31.06% |
| 2024 Q4 | March 28, 2025 | 7.23M | 640.20K | -0.16 | -0.23 | -2.49% |
| 2024 Q3 | November 8, 2024 | — | 214.29K | -0.33 | -0.26 | +9.89% |
| 2024 Q2 | August 13, 2024 | — | — | -0.27 | -0.23 | +0.53% |
| 2024 Q1 | May 10, 2024 | — | — | -0.29 | -0.23 | +3.98% |
| 2023 Q4 | March 22, 2024 | 10.79M | 60.00K | -0.24 | -0.25 | -8.06% |
| 2023 Q3 | November 9, 2023 | — | 70.00K | -0.25 | -0.25 | +6.33% |
| 2023 Q2 | August 14, 2023 | — | 70.00K | -0.22 | -0.22 | +23.55% |
| 2023 Q1 | May 12, 2023 | — | 170.00K | -0.22 | -0.22 | -6.48% |
| 2022 Q4 | March 24, 2023 | 5.00K | 200.00K | -0.21 | -0.24 | -5.83% |
| 2022 Q3 | November 10, 2022 | 31.00K | 203.50K | -0.25 | -0.21 | +3.82% |